Category:
Other Excipients
CAS NO:
/
Standard:
In-house Standards,

"1, Chronic Hepatitis B (CHB); 2, used as the immune response potentiator of the vaccine for the immune-damaged people. " "Highlights: 1, Listed in both Chinese Pharmacopeia and Martindale Pharmacopeia; 2, The first-line drug listed in “CHB Treatment Guidelines of Asian-Pacific Area”. 3, Time to market: 2001 4, Total turnover reached 100 million US dollars in 2013. Registration Dossiers:non-clinical & clinical part, drug substance part and drug product part."